Replies to post #376659 on Amarin Corp Plc (AMRN)

[Whalatane]

HDG. As U know the pricing in the UK / EU will be determined for most patients by govt agencies ...vs the US which seems to be determined by PBM's ( Pharmacy benefit managers )

Germany and I think the UK are larger markets than Sweden so I expect these countries to demand lower prices for access.
Germany has a health budget deficit and will certainly demand more concessions from AMRN for broader access to that market ( or they'll just increase the copay ...which I think was 10 euros ...so they will make it 20 euros copay per I month supply )
JMO
Kiwi

[mrmainstreet]

HDG good to see you back on the board. How do you see things playing out for AMRN? Always interested in your insight.